Intelligent Bio Solutions Inc.
INBS · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $9,071 | $5,829 | $67,040 | $116,544 |
| - Cash | $1,020 | $6,304 | $1,537 | $8,238 |
| + Debt | $282 | $1,146 | $1,915 | $0 |
| Enterprise Value | $8,333 | $671 | $67,418 | $108,306 |
| Revenue | $3,053 | $3,112 | $1,257 | $0 |
| % Growth | -1.9% | 147.6% | – | – |
| Gross Profit | $1,247 | $1,426 | $327 | $0 |
| % Margin | 40.8% | 45.8% | 26% | – |
| EBITDA | -$9,454 | -$9,309 | -$9,474 | -$8,326 |
| % Margin | -309.7% | -299.1% | -753.8% | – |
| Net Income | -$10,569 | -$10,157 | -$10,632 | -$8,306 |
| % Margin | -346.2% | -326.4% | -845.9% | – |
| EPS Diluted | -20 | -63.8 | -105.8 | -113.3 |
| % Growth | 68.7% | 39.7% | 6.6% | – |
| Operating Cash Flow | -$9,677 | -$9,572 | -$7,377 | -$3,358 |
| Capital Expenditures | -$232 | -$221 | -$505 | -$380 |
| Free Cash Flow | -$9,909 | -$9,793 | -$7,883 | -$3,738 |